ID21547A - Kristal-kristal dari turunan benzimidazol dan produksinya - Google Patents
Kristal-kristal dari turunan benzimidazol dan produksinyaInfo
- Publication number
- ID21547A ID21547A IDW990304A ID990304A ID21547A ID 21547 A ID21547 A ID 21547A ID W990304 A IDW990304 A ID W990304A ID 990304 A ID990304 A ID 990304A ID 21547 A ID21547 A ID 21547A
- Authority
- ID
- Indonesia
- Prior art keywords
- substituted
- optionally
- benzimidazol
- derives
- crystals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30336196 | 1996-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID21547A true ID21547A (id) | 1999-06-24 |
Family
ID=17920069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW990304A ID21547A (id) | 1996-11-14 | 1997-11-13 | Kristal-kristal dari turunan benzimidazol dan produksinya |
Country Status (19)
Country | Link |
---|---|
US (1) | US6002011A (pt) |
EP (1) | EP0944617B1 (pt) |
KR (1) | KR100519576B1 (pt) |
CN (2) | CN1171885C (pt) |
AT (1) | ATE240314T1 (pt) |
AU (1) | AU731776B2 (pt) |
CA (1) | CA2269053C (pt) |
DE (1) | DE69722027T2 (pt) |
DK (1) | DK0944617T3 (pt) |
ES (1) | ES2199356T3 (pt) |
HK (1) | HK1020194A1 (pt) |
ID (1) | ID21547A (pt) |
IL (1) | IL129724A (pt) |
NZ (1) | NZ335145A (pt) |
PT (1) | PT944617E (pt) |
TR (1) | TR199901055T2 (pt) |
TW (1) | TW385306B (pt) |
WO (1) | WO1998021201A1 (pt) |
ZA (1) | ZA9710255B (pt) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW385306B (en) * | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
IL142703A (en) | 1998-11-10 | 2006-04-10 | Astrazeneca Ab | Crystalline form of omeprazole |
UA72748C2 (en) | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
JP3926936B2 (ja) | 1998-11-16 | 2007-06-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホキシド誘導体・アセトン錯体およびその製造法 |
CA2360942A1 (en) * | 1999-02-04 | 2000-08-10 | Jorn Bullerdiek | Preparations for preventing and/or treating a tissue change of mesenchymal origin |
TWI275587B (en) | 1999-06-17 | 2007-03-11 | Takeda Chemical Industries Ltd | A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
PL333847A1 (en) * | 1999-06-18 | 2001-01-02 | Inst Farmaceutyczny | Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form |
US6608092B1 (en) | 1999-06-30 | 2003-08-19 | Takeda Chemical Industries, Ltd. | Crystals of benzimidazole compounds |
DK1293507T3 (da) * | 2000-05-15 | 2007-12-27 | Takeda Pharmaceutical | Fremgangsmåde til fremstilling af krystaller |
CA2775616C (en) * | 2000-08-04 | 2013-09-17 | Takeda Pharmaceutical Company Limited | Salts of benzimidazole compound and application thereof |
CA2419067C (en) | 2000-08-18 | 2008-12-23 | Takeda Chemical Industries, Ltd. | Injectable composition comprising benzimidazole compound and strong alkali |
AU2002218506A1 (en) | 2000-12-01 | 2002-06-11 | Takeda Chemical Industries Ltd. | Process for the crystallization of (r)- or (s)-lansoprazole |
DE10140492A1 (de) | 2001-08-17 | 2003-08-14 | Gruenenthal Gmbh | Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung |
ES2426723T3 (es) | 2001-10-17 | 2013-10-24 | Takeda Pharmaceutical Company Limited | Gránulos que contienen gran cantidad de compuesto químico inestable en medio ácido |
MXPA04007995A (es) * | 2002-02-19 | 2004-11-26 | Teva Pharma | Desolvatacion de solvatos de hemicalcio de atorvastatina. |
WO2003082857A2 (en) * | 2002-03-27 | 2003-10-09 | Teva Pharmaceutical Industries Ltd. | Lansoprazole polymorphs and processes for preparation thereof |
KR100873419B1 (ko) * | 2002-06-18 | 2008-12-11 | 페어차일드코리아반도체 주식회사 | 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자 |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
DE60316791T2 (de) * | 2002-08-21 | 2008-07-24 | Teva Pharmaceutical Industries Ltd. | Verfahren zur aufreinigung von lanzoprazol |
EP1837335A1 (en) * | 2002-08-21 | 2007-09-26 | Teva Pharmaceutical Industries Ltd | A method for the purification of Lansoprazole |
EP2596791B1 (en) | 2002-10-16 | 2015-04-01 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
EP1743893A1 (en) | 2002-11-18 | 2007-01-17 | Teva Pharmaceutical Industries Ltd. | Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
EP1465890B1 (en) * | 2002-11-18 | 2007-04-04 | Teva Pharmaceutical Industries Ltd. | Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
CA2515130A1 (en) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries Ltd. | Method of stabilizing lansoprazole |
US7005732B2 (en) * | 2003-10-21 | 2006-02-28 | Honeywell International Inc. | Methods and systems for providing MEMS devices with a top cap and upper sense plate |
TW200526268A (en) * | 2003-12-17 | 2005-08-16 | Takeda Pharmaceutical | Injectable composition |
SE0400410D0 (sv) * | 2004-02-20 | 2004-02-20 | Astrazeneca Ab | New compounds |
AU2005264864B2 (en) | 2004-06-16 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Multiple PPI dosage form |
ES2441970T3 (es) | 2004-09-13 | 2014-02-07 | Takeda Pharmaceutical Company Limited | Método para producir lansoprazol |
EP1681056A1 (en) | 2005-01-14 | 2006-07-19 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for preparing lansoprazole |
CA2599340C (en) | 2005-02-25 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Method for producing granules |
EP1889841A4 (en) * | 2005-06-07 | 2010-04-07 | Takeda Pharmaceutical | CRYSTAL OF A SALT OF A BENZIMIDAZOLE COMPOUND |
WO2006134877A1 (ja) * | 2005-06-13 | 2006-12-21 | Takeda Pharmaceutical Company Limited | 注射剤 |
KR20080081071A (ko) | 2005-12-28 | 2008-09-05 | 다케다 야쿠힌 고교 가부시키가이샤 | 방출 제어 고형 제제 |
KR100758600B1 (ko) * | 2006-01-05 | 2007-09-13 | 주식회사 대웅제약 | 란소프라졸 결정형 a의 제조방법 |
WO2008035189A1 (en) * | 2006-09-22 | 2008-03-27 | Orchid Chemicals & Pharmaceuticals Limited | A method for the purification of lansoprazole |
WO2008068767A2 (en) * | 2006-12-07 | 2008-06-12 | Hetero Drugs Limited | A novel crystalline form of lansoprazole |
ITMI20062481A1 (it) * | 2006-12-22 | 2008-06-23 | Recordati Chem Pharm | Processo per la preparazione di lansoprazolo forma i microcristallino |
EP2098250B1 (en) | 2006-12-28 | 2016-09-28 | Takeda Pharmaceutical Company Limited | Orally disintegrating solid preparation |
EP2227462A1 (en) * | 2007-12-31 | 2010-09-15 | Takeda Pharmaceutical Company Limited | Crystalline solvated forms of (r) -2- [[[3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl]methyl]sulfinyl]-1h-benz imidazole |
CA2671369C (en) | 2008-03-10 | 2011-05-10 | Takeda Pharmaceutical Company Limited | Crystal of benzimidazole compound |
WO2011004387A2 (en) | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | Process for the preparation of dexlansoprazole polymorphic forms |
WO2011098938A1 (en) * | 2010-02-11 | 2011-08-18 | Orchid Chemicals And Pharmaceuticals Limited | Novel solvate of dexlansoprazole |
MX2013006247A (es) | 2010-12-03 | 2014-01-31 | Takeda Pharmaceutical | Tableta oralmente desintegradora. |
AU2011350396A1 (en) | 2010-12-27 | 2013-07-11 | Takeda Pharmaceutical Company Limited | Orally disintegrating tablet |
CN103012369B (zh) * | 2011-05-23 | 2014-04-23 | 中山大学 | 兰索拉唑n晶型及其制备方法和应用 |
CN102180866B (zh) * | 2011-05-23 | 2013-03-13 | 中山大学 | 兰索拉唑晶型及其制备方法和应用 |
US9433632B2 (en) | 2011-11-30 | 2016-09-06 | Takeda Pharmaceutical Company Limited | Dry coated tablet |
US9119769B2 (en) | 2011-12-30 | 2015-09-01 | The Curators Of The University Of Missouri | Method for transforming pharmaceutical crystal forms |
MY184077A (en) | 2013-05-21 | 2021-03-17 | Takeda Pharmaceuticals Co | Orally disintegrable tablet |
CN103539729A (zh) * | 2013-10-14 | 2014-01-29 | 安徽国星生物化学有限公司 | 一种氯甲基吡啶衍生物的工业化生产方法 |
CN103539728A (zh) * | 2013-10-14 | 2014-01-29 | 安徽国星生物化学有限公司 | 一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法 |
CN104829594A (zh) * | 2015-05-15 | 2015-08-12 | 苗怡文 | 一种治疗胃溃疡的药物兰索拉唑化合物 |
CN104817492B (zh) * | 2015-05-22 | 2018-05-18 | 抚州三和医药化工有限公司 | 兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基)吡啶的分离纯化方法 |
KR102649498B1 (ko) | 2023-12-06 | 2024-03-20 | 거산해운(주) | 선사별 실시간 통합 예약 정보를 기반으로 한 화주의 해상 운송 예약 자동화 플랫폼 서비스 제공 방법, 장치 및 시스템 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
DK171989B1 (da) * | 1987-08-04 | 1997-09-08 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler |
DE4018642C2 (de) * | 1990-06-11 | 1993-11-25 | Byk Gulden Lomberg Chem Fab | Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
US5374730A (en) * | 1993-11-04 | 1994-12-20 | Torcan Chemical Ltd. | Preparation of omeprazole and lansoprazole |
GB2297550C2 (en) * | 1995-02-06 | 1997-04-09 | Smithkline Beecham Plc | Paroxetine hydrochloride anhydrate substantially free of bound organic solvent |
TW385306B (en) * | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
-
1997
- 1997-11-05 TW TW086116425A patent/TW385306B/zh not_active IP Right Cessation
- 1997-11-13 AT AT97912445T patent/ATE240314T1/de active
- 1997-11-13 ES ES97912445T patent/ES2199356T3/es not_active Expired - Lifetime
- 1997-11-13 NZ NZ335145A patent/NZ335145A/xx not_active IP Right Cessation
- 1997-11-13 IL IL12972497A patent/IL129724A/en not_active IP Right Cessation
- 1997-11-13 CN CNB971996385A patent/CN1171885C/zh not_active Expired - Lifetime
- 1997-11-13 DE DE69722027T patent/DE69722027T2/de not_active Expired - Lifetime
- 1997-11-13 ID IDW990304A patent/ID21547A/id unknown
- 1997-11-13 AU AU49652/97A patent/AU731776B2/en not_active Ceased
- 1997-11-13 TR TR1999/01055T patent/TR199901055T2/xx unknown
- 1997-11-13 ZA ZA9710255A patent/ZA9710255B/xx unknown
- 1997-11-13 EP EP97912445A patent/EP0944617B1/en not_active Expired - Lifetime
- 1997-11-13 PT PT97912445T patent/PT944617E/pt unknown
- 1997-11-13 CA CA002269053A patent/CA2269053C/en not_active Expired - Lifetime
- 1997-11-13 DK DK97912445T patent/DK0944617T3/da active
- 1997-11-13 WO PCT/JP1997/004136 patent/WO1998021201A1/en active IP Right Grant
- 1997-11-13 CN CNB200410078970XA patent/CN100355749C/zh not_active Expired - Lifetime
- 1997-11-13 KR KR10-1999-7004094A patent/KR100519576B1/ko not_active IP Right Cessation
-
1998
- 1998-01-21 US US09/009,959 patent/US6002011A/en not_active Expired - Lifetime
-
1999
- 1999-11-09 HK HK99105122A patent/HK1020194A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ335145A (en) | 2000-12-22 |
AU4965297A (en) | 1998-06-03 |
KR100519576B1 (ko) | 2005-10-07 |
AU731776B2 (en) | 2001-04-05 |
CN100355749C (zh) | 2007-12-19 |
CN1171885C (zh) | 2004-10-20 |
IL129724A0 (en) | 2000-02-29 |
CN1237167A (zh) | 1999-12-01 |
TR199901055T2 (xx) | 1999-07-21 |
US6002011A (en) | 1999-12-14 |
EP0944617A1 (en) | 1999-09-29 |
DE69722027D1 (de) | 2003-06-18 |
IL129724A (en) | 2004-02-19 |
WO1998021201A1 (en) | 1998-05-22 |
HK1020194A1 (en) | 2000-03-31 |
KR20000053158A (ko) | 2000-08-25 |
ZA9710255B (en) | 1999-05-13 |
PT944617E (pt) | 2003-08-29 |
TW385306B (en) | 2000-03-21 |
DK0944617T3 (da) | 2003-09-01 |
EP0944617B1 (en) | 2003-05-14 |
ATE240314T1 (de) | 2003-05-15 |
CA2269053A1 (en) | 1998-05-22 |
DE69722027T2 (de) | 2004-03-25 |
CN1616457A (zh) | 2005-05-18 |
CA2269053C (en) | 2006-07-18 |
ES2199356T3 (es) | 2004-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID21547A (id) | Kristal-kristal dari turunan benzimidazol dan produksinya | |
HUP9802859A2 (hu) | Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként | |
DE69534975D1 (de) | Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern | |
HRP990167B1 (en) | Sulphinic acid derivatives, method for producing them, and their use | |
DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
MY100665A (en) | 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives. | |
ES8704445A1 (es) | Procedimiento de preparar derivados aminicos | |
FI894061A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita | |
SE8107273L (sv) | 2-oxoazetidinderivat, sett att framstella democh anvendning derav | |
KR850003719A (ko) | 시아노피라졸 제초제에 대한 개량 | |
MY109628A (en) | An improved proces for the preparation of substituted indoline derivatives | |
DK0819108T3 (da) | Fremgangsmåde til fremstilling af galanthaminderivater ved asymmetrisk reduktion | |
DE3778714D1 (de) | Indenothiazolderivate und verfahren zu ihrer herstellung. | |
ATE137747T1 (de) | Aminobenzolverbindungen, herstellung und verwendung | |
BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
HRP20000027B1 (en) | Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds | |
FI20021652A (fi) | Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita | |
ATE195115T1 (de) | Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten | |
PT99280A (pt) | Processo de preparacao de derivados do indolo e de composicoes farmaceuticas | |
ATE144900T1 (de) | Verwendung von xanthinderivaten gegen magengeschwüre | |
CO4940468A1 (es) | Nuevos derivados de naftilpiperacina | |
EA199800931A1 (ru) | Способ получения ингибиторов фосфодиэстеразы iv | |
DE3772852D1 (de) | Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung. | |
HUT39173A (en) | Process for production of derivatives of 3-hydro-amino-2,3-dihydro-benzoxepin |